Prostate Cancer Care Before and After Medicare Eligibility.

Prior studies suggest Medicare eligibility confers significant and substantial reductions in mortality and beneficial increases in health service utilization. We compared 13,882 patients diagnosed with prostate cancer at ages 63 to 64 years with 14,774 patients diagnosed at ages 65 to 66 (controls) in 2004 to 2007. Compared with controls, patients diagnosed with prostate cancer before Medicare eligibility had no statistically significant or meaningful differences in cancer stage, time to treatment, or type of treatment

Lung Cancer Care Before and After Medicare Eligibility.

Uninsured and underinsured near-elderly may not have timely investigation, diagnosis, or care of cancer. Prior studies suggest Medicare eligibility confers significant and substantial reductions in mortality and increases in health service utilization. We compared 2245 patients diagnosed with lung cancer at ages 64.5 to 65 years and 2512 patients aged 65 to 65.5 years, with 2492 patients aged 65.5 to 66 years (controls) in 2000 to 2005. Compared with controls, patients diagnosed with lung cancer before Medicare eligibility had no statistically significant differences in cancer stage, time to treatment, type of treatment, and survival. Study power was sufficient to exclude mortality reductions and health service utilization changes of the magnitude found in prior work, suggesting that typically, appropriate lung cancer care may be sought and delivered regardless of insurance status

Determinations of upper critical field in continuous Ginzburg-Landau model

Novel procedures to determine the upper critical field $B_{c2}$ have been proposed within a continuous Ginzburg-Landau model. Unlike conventional methods, where $B_{c2}$ is obtained through the determination of the smallest eigenvalue of an appropriate eigen equation, the square of the magnetic field is treated as eigenvalue problems so that the upper critical field can be directly deduced. The calculated $B_{c2}$ from the two procedures are consistent with each other and in reasonably good agreement with existing theories and experiments. The profile of the order parameter associated with $B_{c2}$ is found to be Gaussian-like, further validating the methodology proposed. The convergences of the two procedures are also studied.Comment: Revtex4, 8 pages, 4 figures, references modified, figures and table embedde

Uncertainties for Pre- and Post-Launch Radiometric Calibration of Imaging Spectrometers for Multi-Sensor Applications

An important aspect to using imaging spectrometer data is the radiometric characterization and calibration of the sensors and validation of their data products and doing so with error budgets with known traceability. The radiometric accuracy of a given sensor is important for demonstrating the expected quality of data from the sensor. Known traceability allows data from multiple sensors to be directly comparable as will become more important in the near future with the expected launches of multiple imaging spectrometers from multiple countries, agencies, and commercial entities. The current work describes the state of pre- and post-launch radiometric absolute and relative uncertainties and their role in harmonising on-orbit data. Examples of prelaunch uncertainties based on the calibration of EnMAP and the calibration planned for the CLARREO Pathfinder Mission are presented highlighting recent work in the area of detector-based approaches using tunable laser sources. Post-launch calibration approaches for Pathfinder, EnMAP, CHIME, and DESIS including traditional vicarious calibration methods and the challenges of working with commercial data are presented. The vicarious calibration discussion relies on the example of the recently-available RadCalNet data to describe typical methods and challenges that will be faced when harmonising data between imaging spectrometers as well as with multispectral sensors

Could Data Broker Information Threaten Physician Prescribing and Professional Behavior?

Privacy is threatened by the extent of data collected and sold by consumer data brokers. Physicians, as individual consumers, leave a ‘data trail’ in the offline (e.g. through traditional shopping) and online worlds (e.g. through online purchases and use of social media). Such data could easily and legally be used without a physician’s knowledge or consent to influence prescribing practices or other physician professional behavior. We sought to determine the extent to which such consumer data was available on a sample of more than 3,000 physicians, healthcare faculty and healthcare system staff at one university’s health units. Using just work email addresses for these employees we cheaply and quickly obtained external data on nearly two thirds of employees on demographic characteristics (e.g. income, top 10% national wealth, children at home, married), purchases (e.g. baby products, cooking, sports), behavior (e.g. charitable donor, discount shopper) and interests (e.g. automotive, health and wellness). Consumer data brokers have valuable, cost-effective and detailed information on many healthcare professionals, including data that could be used to segment, target, detail and generally market to physicians in ways that seem under‐appreciated. We call for greater attention to this potential aspect of physician-industry relationships